Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,828,495
-
Share change
-
0
-
Total reported value
-
$807,408,963
-
Price per share
-
$68.28
-
Number of holders
-
85
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q4 2013
As of 31 Dec 2013,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,828,495 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, SAC Capital Advisors LP, Visium Asset Management, LP, MILLENNIUM MANAGEMENT LLC, BAKER BROS. ADVISORS LP, State Street Corp, ALLIANCEBERNSTEIN L.P., Polar Capital LLP, and Redmile Group, LLC.
This page lists
85
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.